We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

BODITECH

Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. Its products include automatic ... read more Featured Products: More products

Download Mobile App





Boditech Presents Latest IVD Solutions at ECCMID 2022

By LabMedica International staff writers
Posted on 26 Apr 2022
Print article
Image: Boditech’s latest IVD solutions at ECCMID 2022 (Photo courtesy of Boditech)
Image: Boditech’s latest IVD solutions at ECCMID 2022 (Photo courtesy of Boditech)

Boditech Med (Gang-won-do, Korea) presented its latest IVD solutions, including RDTs, fluorescence immunoassay tests, and PCR tests, at ECCMID 2022.

Boditech demonstrated its AFIAS-10 automated immunoassay analyzer with blood collection tube, including an all-in-one cartridge system. The CE Marked AFIAS-10 is a unique integrated sample-to-answer system that can execute 10 parallel tests for each different parameter. It provides a quick and simplified operation and reliable test results with automatically collection of sample from a blood tube. Also on display was Boditech’s ichroma II, a compact and easy-to-use, fluorescence based POCT immunoassay analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases. Alongside this, Boditech presented ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters. ichroma III accepts cartridges for various biomarkers in random sequence and processes them in a preset temperature, even combines test parameters with differing incubation period.

At this year’s ECCMID, Boditech showcased its NuActor bench-top & automated nucleic acid (RNA/DNA) extraction system used with a ready-to-use cartridge that can be stored at room temperature as a table-top extractor. It can extract concentrated high-purity nucleic acids from a small volume of samples such as blood, cultured cells, and animal tissues quickly and easily. Visitors to Boditech’s ECCMID booth also experienced ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges. ExAmplar employs relatively fast thermal cycles (~40 sec) and can deliver the DNA and RNA test results in 30 and 45~55 minutes, respectively. The system runs with dedicated 8-well plates. The reagents for the test come in a dry format, which can be stored at room temperature.

Related Links:
Boditech Med 

Platinum Supplier
Hormonal Test
Endocrine Array
New
Anti-HIV 1/2 ELISA Test
HIV 1/2 Antibody (3rd) Test Kit (ELISA)
New
Allergen-Specific IgG/IgG4 Enzymimmunoassay
ALLERgen Specific IgG/IgG4 ELISA Kits
New
Automated Immunoassay Analyzer
cobas e 411

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Mindray ToRCH reagents deliver excellent seroconversion sensitivity (Photo courtesy of Mindray)

Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel

Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and... Read more

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.